These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

546 related items for PubMed ID: 16315307

  • 1. The effect of HLA mismatches, shared cross-reactive antigen groups, and shared HLA-DR antigens on the outcome after pediatric liver transplantation.
    Sieders E, Hepkema BG, Peeters PM, TenVergert EM, de Jong KP, Porte RJ, Bijleveld CM, van den Berg AP, Lems SP, Gouw AS, Slooff MJ.
    Liver Transpl; 2005 Dec; 11(12):1541-9. PubMed ID: 16315307
    [Abstract] [Full Text] [Related]

  • 2. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
    Herzberg GZ, Rossi AF, Courtney M, Gelb BD.
    J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
    [Abstract] [Full Text] [Related]

  • 3. Influence of human leukocyte antigen matching on liver allograft survival and rejection: "the dualistic effect".
    Donaldson P, Underhill J, Doherty D, Hayllar K, Calne R, Tan KC, O'Grady J, Wight D, Portmann B, Williams R.
    Hepatology; 1993 Jun; 17(6):1008-15. PubMed ID: 8514248
    [Abstract] [Full Text] [Related]

  • 4. HLA compatibility and liver transplant outcome. Improved patient survival by HLA and cross-matching.
    Nikaein A, Backman L, Jennings L, Levy MF, Goldstein R, Gonwa T, Stone MJ, Klintmalm G.
    Transplantation; 1994 Oct 15; 58(7):786-92. PubMed ID: 7940711
    [Abstract] [Full Text] [Related]

  • 5. HLA-DR matching in organ allocation: balance between waiting time and rejection in pediatric kidney transplantation.
    Vu LT, Baxter-Lowe LA, Garcia J, McEnhill M, Summers P, Hirose R, Lee M, Stock PG.
    Arch Surg; 2011 Jul 15; 146(7):824-9. PubMed ID: 21768429
    [Abstract] [Full Text] [Related]

  • 6. The effect of HLA class I (A and B) and class II (DR) compatibility on liver transplantation outcomes: an analysis of the OPTN database.
    Navarro V, Herrine S, Katopes C, Colombe B, Spain CV.
    Liver Transpl; 2006 Apr 15; 12(4):652-8. PubMed ID: 16555339
    [Abstract] [Full Text] [Related]

  • 7. Influence of HLA compatibility and lymphocyte cross-matching on acute cellular rejection following living donor adult liver transplantation.
    Suehiro T, Shimada M, Kishikawa K, Shimura T, Soejima Y, Yoshizumi T, Hashimoto K, Mochida Y, Maehara Y, Kuwano H.
    Liver Int; 2005 Dec 15; 25(6):1182-8. PubMed ID: 16343070
    [Abstract] [Full Text] [Related]

  • 8. Influence of donor/recipient HLA-matching on outcome and recurrence of hepatitis C after liver transplantation.
    Langrehr JM, Puhl G, Bahra M, Schmeding M, Spinelli A, Berg T, Schönemann C, Krenn V, Neuhaus P, Neumann UP.
    Liver Transpl; 2006 Apr 15; 12(4):644-51. PubMed ID: 16555324
    [Abstract] [Full Text] [Related]

  • 9. Influence of mismatching of HLA cross-reactive groups on cadaveric kidney transplantation.
    Hwang SH, Oh HB, Shin ES, Yew M, Kim SC, Han DJ.
    Transplant Proc; 2005 Dec 15; 37(10):4194-8. PubMed ID: 16387076
    [Abstract] [Full Text] [Related]

  • 10. Influence of human leukocyte antigen mismatching on rejection development and allograft survival in liver transplantation: is the relevance of HLA-A locus matching being underestimated?
    Muro M, López-Álvarez MR, Campillo JA, Marin L, Moya-Quiles MR, Bolarín JM, Botella C, Salgado G, Martínez P, Sánchez-Bueno F, López-Hernández R, Boix F, Bosch A, Martínez H, de la Peña-Moral JM, Pérez N, Robles R, García-Alonso AM, Minguela A, Miras M, Alvarez-López MR.
    Transpl Immunol; 2012 Mar 15; 26(2-3):88-93. PubMed ID: 22129495
    [Abstract] [Full Text] [Related]

  • 11. Increased late hepatic artery thrombosis rate and decreased graft survival after liver transplants with zero cross-reactive group mismatches.
    Sawyer RG, Pelletier SJ, Spencer CE, Pruett TL, Isaacs RB.
    Liver Transpl; 2000 Mar 15; 6(2):229-36. PubMed ID: 10719025
    [Abstract] [Full Text] [Related]

  • 12. Influence of human leukocyte antigen matching on long-term outcome after lung transplantation.
    Wisser W, Wekerle T, Zlabinger G, Senbaclavaci O, Zuckermann A, Klepetko W, Wolner E.
    J Heart Lung Transplant; 1996 Dec 15; 15(12):1209-16. PubMed ID: 8981206
    [Abstract] [Full Text] [Related]

  • 13. Influence of HLA matching on survival in heart transplantation.
    Almenar L, Maeso ML, Martínez-Dolz L, Rueda J, Palomar CG, Sáez AO, Vives MA, Tort MD, Pérez MP.
    Transplant Proc; 2005 Nov 15; 37(9):4001-5. PubMed ID: 16386610
    [Abstract] [Full Text] [Related]

  • 14. Long-term outcome of human leukocyte antigen mismatching in liver transplantation: results of the National Institute of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database.
    Balan V, Ruppert K, Demetris AJ, Ledneva T, Duquesnoy RJ, Detre KM, Wei YL, Rakela J, Schafer DF, Roberts JP, Everhart JE, Wiesner RH.
    Hepatology; 2008 Sep 15; 48(3):878-88. PubMed ID: 18752327
    [Abstract] [Full Text] [Related]

  • 15. Human leukocyte antigen and adult living-donor liver transplantation outcomes: an analysis of the organ procurement and transplantation network database.
    Jakab SS, Navarro VJ, Colombe BW, Daskalakis C, Herrine SK, Rossi S.
    Liver Transpl; 2007 Oct 15; 13(10):1405-13. PubMed ID: 17902126
    [Abstract] [Full Text] [Related]

  • 16. HLA-DR matching improves survival after heart transplantation: is it time to change allocation policies?
    Kaczmarek I, Deutsch MA, Rohrer ME, Beiras-Fernandez A, Groetzner J, Daebritz S, Schmoeckel M, Spannagl M, Meiser B, Reichart B.
    J Heart Lung Transplant; 2006 Sep 15; 25(9):1057-62. PubMed ID: 16962466
    [Abstract] [Full Text] [Related]

  • 17. Rejection in heart transplantation strongly correlates with HLA-DR antigen mismatch.
    Sheldon S, Hasleton PS, Yonan NA, Rhaman AN, Deiraniya AK, Campbell CS, Brooks NH, Dyer PA.
    Transplantation; 1994 Sep 27; 58(6):719-22. PubMed ID: 7940693
    [Abstract] [Full Text] [Related]

  • 18. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May 27; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]

  • 19. Simpler and equitable allocation of kidneys from postmortem donors primarily based on full HLA-DR compatibility.
    Doxiadis II, de Fijter JW, Mallat MJ, Haasnoot GW, Ringers J, Persijn GG, Claas FH.
    Transplantation; 2007 May 15; 83(9):1207-13. PubMed ID: 17496537
    [Abstract] [Full Text] [Related]

  • 20. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.